URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l'antihistaminique azélastine afin de lutter contre la COVID-19 Be sure to Be at liberty to attend our event if we at any time choose to make it .. and you also may also be welcome to share your own private press https://robertq009lyi3.daneblogger.com/profile